COVID-19 and hypertension S Kulkarni, BL Jenner, I Wilkinson Journal of the renin-angiotensin-aldosterone system 21 (2), 1470320320927851, 2020 | 81 | 2020 |
Niclosamide—a promising treatment for COVID‐19 S Singh, A Weiss, J Goodman, M Fisk, S Kulkarni, I Lu, J Gray, R Smith, ... British journal of pharmacology 179 (13), 3250-3267, 2022 | 46 | 2022 |
Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: a retrospective study S Kulkarni, R Rao, JDH Goodman, K Connolly, KM O'Shaughnessy Medicine 100 (14), e24654, 2021 | 39 | 2021 |
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients-mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19–Repurposed Drugs (TACTIC-R): A … S Kulkarni, M Fisk, M Kostapanos, E Banham-Hall, S Bond, ... Trials 21, 1-3, 2020 | 33 | 2020 |
Hepatic pathology in AIDS: a pathological study from Mumbai, India DN Lanjewar, RJ Rao, SB Kulkarni, SK Hira HIV medicine 5 (4), 253-257, 2004 | 25 | 2004 |
Hypertension management in 2030: a kaleidoscopic view S Kulkarni Journal of Human Hypertension 35 (9), 812-817, 2021 | 19 | 2021 |
Management of hypertensive crisis: British and Irish Hypertension Society Position document S Kulkarni, M Glover, V Kapil, SML Abrams, S Partridge, T McCormack, ... Journal of human hypertension 37 (10), 863-879, 2023 | 17 | 2023 |
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized … IN Lu, S Kulkarni, M Fisk, M Kostapanos, E Banham-Hall, S Kadyan, ... Trials 21, 1-3, 2020 | 16 | 2020 |
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank H Pavey, S Kulkarni, A Wood, Y Ben-Shlomo, P Sever, C McEniery, ... PLoS One 17 (11), e0276781, 2022 | 8 | 2022 |
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society L Faconti, S Kulkarni, C Delles, V Kapil, P Lewis, M Glover, ... Journal of Human Hypertension 38 (1), 8-18, 2024 | 7 | 2024 |
Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis S Kulkarni, H Durham, L Glover, O Ather, V Phillips, S Nemes, L Cousens, ... BMJ open 12 (12), e061476, 2022 | 6 | 2022 |
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial FC Hall, J Cheriyan, AP Cope, J Galloway, I Wilkinson, S Bond, S Norton, ... The Lancet Respiratory Medicine 11 (12), 1064-1074, 2023 | 5 | 2023 |
Research and development of low cost processes for integrated solar arrays CD Graham, S Kulkarni, E Louis NASA STI/Recon Technical Report N 77, 26670, 1976 | 5 | 1976 |
Sustainable medicines use in clinical practice: a clinical pharmacological view on eco‐pharmaco‐stewardship E Adeyeye, BJM New, F Chen, S Kulkarni, M Fisk, JJ Coleman British journal of clinical pharmacology 88 (7), 3023-3029, 2022 | 4 | 2022 |
Two Cases of Severe Hypertension in JAK2 Mutation‐Positive Myeloproliferative Neoplasms R Rao, S Kulkarni, IB Wilkinson Case reports in vascular medicine 2020 (1), 8887423, 2020 | 3 | 2020 |
Quo vadis (where are you going) pharmacovigilance? S Kulkarni, M Rieder, R Likic British journal of clinical pharmacology 89 (2), 2023 | 2 | 2023 |
CONNed in pregnancy S Kulkarni, AF Dominiczak, RM Touyz, JD Spence, D Batlle, M Barigou, ... Hypertension 78 (1), 241-249, 2021 | 2 | 2021 |
1.5 Age and Sex Differences in the Association of Brachial and Central Blood Pressure Variability with Arterial Stiffness S Yu, K Connolly, S Kulkarni, V Selvarajah, J Woodcock-Smith, ... Artery Research 25 (Suppl 1), S4-S5, 2019 | 1 | 2019 |
Investigation and management of young-onset hypertension: British and Irish hypertension society position statement S Kulkarni, L Faconti, S Partridge, C Delles, M Glover, P Lewis, A Gray, ... Journal of Human Hypertension, 1-11, 2024 | | 2024 |
Adrenoceptors and Hypertension S Kulkarni, IB Wilkinson | | 2024 |